الوصف
Adverse event profiles from the synbiotic trial are tabulated, documenting safety and tolerability of the probiotic-prebiotic combination.
Figure 16
Source Paper
The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant …Cite This Figure
![Figure 16: Adverse event profiles from the synbiotic trial are tabulated, documenting safety and tolerability of the probiotic-prebiotic combination.]() > Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." *Nutrients*, 2020. PMID: [32635661](https://pubmed.ncbi.nlm.nih.gov/32635661/)
<figure> <img src="" alt="Adverse event profiles from the synbiotic trial are tabulated, documenting safety and tolerability of the probiotic-prebiotic combination." /> <figcaption>Figure 16. Adverse event profiles from the synbiotic trial are tabulated, documenting safety and tolerability of the probiotic-prebiotic combination.<br> Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32635661/">32635661</a></figcaption> </figure>
أدلة ذات صلة
B
Bifidobacterium longum لـ Irritable Bowel Syndrome (IBS)
B
التقييم B · 4 دراسات
Galactooligosaccharides (GOS) لـ Irritable Bowel Syndrome (IBS)
B
التقييم B · 3 دراسات
Lactobacillus acidophilus لـ Irritable Bowel Syndrome (IBS)
D
التقييم B · 3 دراسات
Fructooligosaccharides (FOS) لـ Irritable Bowel Syndrome (IBS)
التقييم D · 2 دراسات